Five things to know:
1. Reported revenue for full-year 2019 increased 3.1 percent to $1.52 billion, compared to 2018.
2. Global neurosurgery sales increased 7 percent year-over-year to $183.1 million.
3. Total orthopedics and tissue technology revenues rose 1.6 percent on an organic basis to $136 million, compared to the same period for the prior year.
4. For 2020, the company anticipates full-year adjusted earnings per diluted share to be in the range of $3 to $3.05.
5. Integra plans to grow its OTT line this year to “become a market leader in regenerative technologies,” Peter Arduini, president and CEO at Integra, said during the fourth quarter earnings call, transcribed by The Motley Fool.
More articles on devices:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.